{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:00:48Z","timestamp":1784566848688,"version":"3.55.0"},"reference-count":104,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Uterine fibroids (leiomyomas) are the most common benign tumors in women of reproductive age and represent a significant cause of abnormal uterine bleeding, pelvic pain, infertility, and reduced quality of life. Contemporary management has evolved toward individualized, uterus-sparing approaches, incorporating pharmacological and minimally invasive strategies alongside traditional surgical methods. Methods: This narrative review was conducted based on a comprehensive search of PubMed\/MEDLINE, Scopus, and Web of Science databases for studies published between January 2010 and December 2025. The search strategy combined Medical Subject Headings (MeSH) and free-text terms related to uterine fibroids and their management. Eligible studies included clinical trials, systematic reviews, and meta-analyses focusing on pharmacological, minimally invasive, and surgical treatments in adult women. The review was prepared in accordance with the Scale for the Assessment of Narrative Review Articles (SANRA) recommendations to improve methodological transparency and quality of reporting. Results: A total of 97 studies were included in the qualitative synthesis. Minimally invasive techniques, including uterine artery embolization (UAE), radiofrequency ablation (RFA), and high-intensity focused ultrasound (HIFU), demonstrate high efficacy in symptom control and improvement of quality of life, with shorter recovery times and lower complication rates compared to conventional surgery. However, their impact on fertility remains variable and requires careful patient selection. Pharmacological therapies, particularly GnRH analogues and antagonists, effectively reduce bleeding and fibroid volume, although their long-term use is limited by side effects. Conclusions: The management of uterine fibroids should be individualized, taking into account symptom severity, fibroid characteristics, patient age, and reproductive plans. Minimally invasive and pharmacological treatments represent effective alternatives to surgery in appropriately selected patients, while surgical approaches remain essential in advanced or refractory cases. Future research should focus on optimizing personalized treatment strategies and evaluating long-term outcomes, particularly regarding fertility and recurrence.<\/jats:p>","DOI":"10.3390\/jcm15124632","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:57:58Z","timestamp":1781513878000},"page":"4632","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contemporary Management of Uterine Fibroids"],"prefix":"10.3390","volume":"15","author":[{"given":"Olga","family":"Po\u0142ukord","sequence":"first","affiliation":[{"name":"Department of Maternal and Child Health and Minimally Invasive Gynecologic Surgery, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"J\u0119drzejak","sequence":"additional","affiliation":[{"name":"The Student of Faculty of Medicine, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Loba","sequence":"additional","affiliation":[{"name":"The Student of Faculty of Medicine, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Depczy\u0144ska","sequence":"additional","affiliation":[{"name":"The Student of Faculty of Medicine, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Radziszewska","sequence":"additional","affiliation":[{"name":"The Student of Faculty of Medicine, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dobrochna","family":"Stachecka","sequence":"additional","affiliation":[{"name":"The Student of Faculty of Medicine, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Wilczak","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health and Minimally Invasive Gynecologic Surgery, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-8353","authenticated-orcid":false,"given":"Karolina","family":"Chmaj-Wierzchowska","sequence":"additional","affiliation":[{"name":"Department of Maternal and Child Health and Minimally Invasive Gynecologic Surgery, Poznan University of Medical Sciences, 60-701 Poznan, Poland"},{"name":"Laboratory of Advanced Interventional Therapies in Gynecology and Urogynecology, Poznan University of Medical Sciences, 60-701 Poznan, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"key":"ref_1","first-page":"100","article-title":"Uterine Fibroids: Diagnosis and Treatment","volume":"95","author":"Buchanan","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1152\/physrev.00010.2024","article-title":"Uterine Fibroids","volume":"105","author":"Bulun","year":"2025","journal-title":"Physiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2024.04.041","article-title":"The modern management of uterine fibroids-related abnormal uterine bleeding","volume":"122","author":"Vannuccini","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2024.02.048","article-title":"Pathogenesis of uterine fibroids: Current understanding and future directions","volume":"122","author":"Dolmans","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mici\u0107, J., Macura, M., Andji\u0107, M., Ivanovi\u0107, K., Dotli\u0107, J., Mici\u0107, D.D., Arsenijevi\u0107, V., Stojni\u0107, J., Bila, J., and Babi\u0107, S. (2024). Currently Available Treatment Modalities for Uterine Fibroids. Medicina, 60.","DOI":"10.3390\/medicina60060868"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.fertnstert.2024.02.049","article-title":"Uterine fibroid-related infertility: Mechanisms and management","volume":"122","author":"Donnez","year":"2024","journal-title":"Fertil. Steril."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E775","DOI":"10.1503\/cmaj.211530","article-title":"Uterine fibroids in pregnancy","volume":"194","author":"Sobel","year":"2022","journal-title":"Can. Med. Assoc. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ijgo.70612","article-title":"Fibroids and pregnancy","volume":"172","author":"Ramasauskaite","year":"2026","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Li, H., Hu, Z., Fan, Y., and Hao, Y. (2024). The influence of uterine fibroids on adverse outcomes in pregnant women: A meta-analysis. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06545-5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ijgo.70493","article-title":"Image-guided therapies for uterine fibroids","volume":"171","author":"Lewis","year":"2025","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4103\/GMIT.GMIT_50_19","article-title":"Evaluation of uterine artery embolization on myoma shrinkage: Results from a large cohort analysis","volume":"8","author":"Garzon","year":"2019","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"20220121","DOI":"10.1259\/bjr.20220121","article-title":"An update on uterine artery embolization for uterine leiomyomata and adenomyosis of the uterus","volume":"96","year":"2023","journal-title":"Br. J. Radiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19252","DOI":"10.1038\/s41598-024-69754-0","article-title":"Systematic review and meta-analysis of current evidence in uterine artery embolization vs myomectomy for symptomatic uterine fibroids","volume":"14","author":"Peng","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00270-012-0388-y","article-title":"Uterine artery embolization versus laparoscopic uterine artery occlusion: Outcomes of a prospective nonrandomized clinical trial","volume":"35","author":"Mara","year":"2012","journal-title":"Cardiovasc. Interv. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e16699","DOI":"10.5812\/ircmj.16699","article-title":"Uterine artery embolization for symptomatic fibroids: A review of evidence","volume":"15","author":"Firouznia","year":"2013","journal-title":"Iran. Red Crescent Med. J."},{"key":"ref_17","first-page":"e61530","article-title":"The Lublin protocol of uterine artery embolization in the treatment of symptomatic uterine fibroids","volume":"163","author":"Szkodziak","year":"2020","journal-title":"J. Vis. Exp."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/a-0893-4807","article-title":"Uterine artery embolization (UAE) for fibroid treatment: Results of the 7th radiological gynecological expert meeting","volume":"79","author":"David","year":"2019","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ogc.2005.12.009","article-title":"Uterine artery embolization as a treatment option for uterine myomas","volume":"33","author":"Marshburn","year":"2006","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0042-1758050","article-title":"Evidences in uterine artery embolization: A radiologist\u2019s primer","volume":"7","author":"Bellala","year":"2023","journal-title":"J. Clin. Interv. Radiol. ISVIR"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Waldron, M.G., Kassamani, Y.W., O\u2019mahony, A.T., O\u2019mahony, S.M., O\u2019sullivan, O.E., Power, S.P., Spence, L., Maher, M.M., O\u2019connor, O.J., and Buckley, M.M. (2022). Uterine artery embolisation and post-embolisation syndrome: A systematic review. Diagnostics, 12.","DOI":"10.3390\/diagnostics12122916"},{"key":"ref_22","first-page":"205","article-title":"Influence of uterine artery embolisation on ovarian reserve, fertility, and pregnancy outcomes","volume":"15","author":"Czuczwar","year":"2016","journal-title":"Prz. Menopauzalny"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13669-016-0183-x","article-title":"Radiofrequency ablation of uterine fibroids: A review","volume":"5","author":"Lee","year":"2016","journal-title":"Curr. Obstet. Gynecol. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1002\/mco2.746","article-title":"Radiofrequency ablation: Mechanisms and clinical applications","volume":"5","author":"Wu","year":"2024","journal-title":"MedComm"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.xfre.2024.07.001","article-title":"Transvaginal radiofrequency ablation: Therapeutic option for symptomatic uterine fibroids in women with reproductive desires","volume":"5","year":"2024","journal-title":"F&S Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102812","DOI":"10.1016\/j.jogoh.2024.102812","article-title":"Outcomes of transvaginal radiofrequency ablation for symptomatic leiomyomas","volume":"53","author":"Ariza","year":"2024","journal-title":"J. Gynecol. Obstet. Hum. Reprod."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e16216","DOI":"10.1111\/jog.16216","article-title":"Clinical outcomes after 2-year follow-up of transvaginal radiofrequency ablation of symptomatic uterine fibroids","volume":"51","year":"2025","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/AOG.0000000000005826","article-title":"Pregnancy outcomes after transvaginal radiofrequency ablation of leiomyomas","volume":"145","author":"Rey","year":"2025","journal-title":"Obstet. Gynecol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chmaj-Wierzchowska, K., Lach, A., Bednarek, K., Nowak, A., Mruczy\u0144ski, A., Bruszewski, A., Piekarski, P., Malinger, A., and Wilczak, M. (2025). Transvaginal uterine fibroid radiofrequency ablation (TV-RFA): Retrospective analysis and preliminary report. Life, 15.","DOI":"10.3390\/life15121841"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00404-025-08127-y","article-title":"Combined transcervical radiofrequency ablation and hysteroscopic myomectomy: Expanding treatment to diverse fibroid types","volume":"312","author":"Piriyev","year":"2025","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.13638","article-title":"Transcervical fibroid ablation with the Sonata system for treatment of submucous and large uterine fibroids","volume":"155","author":"Shifrin","year":"2021","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/gyn.2019.0012","article-title":"Transcervical radiofrequency ablation of symptomatic uterine fibroids: 2-year results of the SONATA pivotal trial","volume":"35","author":"Miller","year":"2019","journal-title":"J. Gynecol. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jmig.2024.09.045","article-title":"Transcervical fibroid ablation (TFA): Pregnancy outcomes","volume":"31","author":"Toub","year":"2024","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/gyn.2021.0136","article-title":"Pregnancy outcomes after transcervical radiofrequency ablation of uterine fibroids with the Sonata system","volume":"38","author":"Christoffel","year":"2022","journal-title":"J. Gynecol. Surg."},{"key":"ref_35","unstructured":"Wray, J.K., Dixon, B., and Przkora, R. (2025). Radiofrequency ablation. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00330-021-08156-6","article-title":"High-intensity focused ultrasound (HIFU) ablation versus surgical interventions for symptomatic uterine fibroids: A meta-analysis","volume":"32","author":"Liu","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5603\/GP.a2021.0202","article-title":"Minimally invasive treatment options for uterine fibroids\u2014State of the art 2021","volume":"93","author":"Krzyzanowski","year":"2022","journal-title":"Ginekol. Pol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wu, L., Zhong, L., Zheng, Q., Huang, L., Lin, F., Chen, Z., and Lian, C. (2025). Application of high intensity focused ultrasound in the treatment of uterine fibroids in overweight\/obese women. BMC Womens Health, 25.","DOI":"10.1186\/s12905-025-03797-x"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jmig.2021.06.002","article-title":"Comparison of high-intensity focused ultrasound and conventional surgery for patients with uterine myomas: A systematic review and meta-analysis","volume":"28","author":"Tsai","year":"2021","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_40","unstructured":"National Institute for Health and Care Excellence (2011). Magnetic Resonance Image-Guided Transcutaneous Focused Ultrasound for Uterine Fibroids (IPG413), NICE."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1080\/02656736.2021.1954245","article-title":"Efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids <300 cm3: A meta-analysis","volume":"38","author":"Yu","year":"2021","journal-title":"Int. J. Hyperth."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Madueke-Laveaux, O.S., Elsharoud, A., and Al-Hendy, A. (2021). Long-term risks of hysterectomy for benign indication\u2014A systematic review. J. Clin. Med., 10.","DOI":"10.3390\/jcm10225335"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1235","DOI":"10.61919\/z3vsnm24","article-title":"Intra-operative and post-operative common complications of hysterectomy","volume":"4","author":"Shahzadi","year":"2026","journal-title":"J. Health Wellness Community Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jvir.2025.02.026","article-title":"Hysterectomy and myomectomy versus uterine artery embolization for symptomatic fibroids and adenomyosis: Trends and adverse events in 70,000 patients","volume":"36","author":"Deipolyi","year":"2025","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1007\/s11701-023-01724-6","article-title":"Robotic-assisted benign hysterectomy compared with laparoscopic, vaginal, and open surgery: A systematic review and meta-analysis","volume":"17","author":"Lenfant","year":"2023","journal-title":"J. Robot. Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00003081-200106000-00024","article-title":"Traditional surgical approaches to uterine fibroids: Abdominal myomectomy and hysterectomy","volume":"44","author":"Guarnaccia","year":"2001","journal-title":"Clin. Obstet. Gynecol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"154","DOI":"10.70779\/aijshs.v4i9.304","article-title":"Comparison between abdominal, vaginal, and laparoscopic hysterectomy: Advances, indications and outcomes","volume":"4","author":"Ruiz","year":"2025","journal-title":"Asclepius Int. J. Sci. Health Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e096265","DOI":"10.1136\/bmjopen-2024-096265","article-title":"Comparison of complications and recovery after laparoscopic and abdominal hysterectomy (LAVA trial)","volume":"15","author":"Antoun","year":"2025","journal-title":"BMJ Open"},{"key":"ref_49","first-page":"1097","article-title":"Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: A systematic review","volume":"109","author":"Lethaby","year":"2002","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"ref_50","first-page":"CD000547","article-title":"Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids","volume":"2","author":"Lethaby","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/AOG.0000000000005434","article-title":"Vaginal hysterectomy compared with laparoscopic hysterectomy in benign gynecologic conditions: A systematic review and meta-analysis","volume":"142","author":"Azadi","year":"2023","journal-title":"Obstet. Gynecol."},{"key":"ref_52","first-page":"197","article-title":"Clinical and cost comparisons for hysterectomy via abdominal, laparoscopic, vaginal and robot-assisted approaches","volume":"64","author":"Landeen","year":"2011","journal-title":"South Dak. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2014.03.010","article-title":"Cost analysis of robot-assisted hysterectomy in malignant and benign conditions","volume":"177","author":"Tapper","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tjog.2012.01.003","article-title":"Review of myomectomy","volume":"51","author":"Horng","year":"2012","journal-title":"Taiwan J. Obstet. Gynecol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Cianci, S., Gulino, F.A., Palmara, V., La Verde, M., Ronsini, C., Romeo, P., Occhipinti, S., Incognito, G.G., Capozzi, V.A., and Restaino, S. (2024). Exploring surgical strategies for uterine fibroid treatment: A comprehensive review of literature on open and minimally invasive approaches. Medicina, 60.","DOI":"10.3390\/medicina60010064"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.gco.0000233934.13684.cb","article-title":"Pregnancy outcomes following treatment for fibroids: Uterine fibroid embolization versus laparoscopic myomectomy","volume":"18","author":"Goldberg","year":"2006","journal-title":"Curr. Opin. Obstet. Gynecol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4103\/gmit.gmit_152_23","article-title":"Myomectomy: Choosing the surgical approach\u2014A systematic review","volume":"13","author":"Paredes","year":"2024","journal-title":"Gynecol. Minim. Invasive Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10397-011-0699-z","article-title":"Clinical outcome after laparoscopic and open abdominal myomectomy","volume":"9","author":"Majak","year":"2012","journal-title":"Gynecol. Surg."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/aogs.12920","article-title":"Trial of labor after myomectomy and uterine rupture: A systematic review","volume":"95","author":"Gimovsky","year":"2016","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10397-014-0842-8","article-title":"Risk of uterine rupture after myomectomy: A systematic review and meta-analysis","volume":"11","author":"Claeys","year":"2014","journal-title":"Gynecol. Surg."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists (2021). Management of symptomatic uterine leiomyomas: ACOG practice bulletin No. 228. Obstet. Gynecol., 137, e100\u2013e115.","DOI":"10.1097\/AOG.0000000000004401"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Sznurkowski, J.J., and Wnuk, J. (2025). Feasibility of laparoscopic removal of the largest documented uterine fibroid without morcellation. Reports, 8.","DOI":"10.3390\/reports8020071"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jmig.2025.07.002","article-title":"Safety of in-bag morcellation during laparoscopic myomectomy and hysterectomy: Systematic review and meta-analysis","volume":"33","author":"Chene","year":"2026","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_64","unstructured":"Arulkumaran, S., and Regan, L. (2019). Minimally invasive myomectomy. The Global Library of Women\u2019s Medicine (GLOWM), ISGE."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11701-024-01953-3","article-title":"Robotic surgery in myomectomies: Systematic review and meta-analysis","volume":"18","author":"Mourad","year":"2024","journal-title":"J. Robot. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/s12957-023-03104-8","article-title":"Robot-assisted versus laparoscopic myomectomy: Systematic evaluation and meta-analysis","volume":"21","author":"Sheng","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.29063\/ajrh2025\/v29i12.22","article-title":"Comparative analysis of robotic-assisted laparoscopic myomectomy versus traditional abdominal and laparoscopic myomectomy: A meta analysis and systematic review","volume":"29","author":"Alghamdi","year":"2025","journal-title":"Afr. J. Reprod. Health"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/humupd\/dmm041","article-title":"Hysteroscopic myomectomy: Review of surgical techniques","volume":"14","author":"Mazzon","year":"2008","journal-title":"Hum. Reprod. Update"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lasmar, R.B., Lasmar, B.P., and Moawad, N.S. (2022). Hysteroscopic myomectomy. Medicina, 58.","DOI":"10.3390\/medicina58111627"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejogrb.2021.11.434","article-title":"Hysteroscopic myomectomy: The guidelines of the International Society for Gynecologic Endoscopy (ISGE)","volume":"268","author":"Loddo","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jmig.2023.05.013","article-title":"Incidence of intrauterine adhesions after hysteroscopic myomectomy in patients seeking fertility","volume":"30","author":"Zhang","year":"2023","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.contraception.2010.05.006","article-title":"Translational research with progesterone receptor modulator motivated by the use of levonorgestrel-releasing intrauterine system","volume":"82","author":"Maruo","year":"2010","journal-title":"Contraception"},{"key":"ref_75","first-page":"CD008994","article-title":"Progestogens or progestogen-releasing intrauterine systems for uterine fibroids","volume":"2020","author":"Sangkomkamhang","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Donnez, J. (2020). Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123948"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/14656566.2023.2248890","article-title":"GnRH agonists and antagonists in therapy of symptomatic uterine fibroids\u2014Current roles and future perspectives","volume":"24","author":"Ciebiera","year":"2023","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00404-025-07932-9","article-title":"Efficacy of GnRH antagonists in the treatment of uterine fibroids: A meta-analysis","volume":"311","author":"Quevedo","year":"2025","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_79","first-page":"CD010770","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"4","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_81","first-page":"43","article-title":"Farmakoterapia mi\u0119\u015bniak\u00f3w macicy","volume":"2","author":"Pietrzak","year":"2017","journal-title":"Ginekol. Perinatol. Prakt."},{"key":"ref_82","first-page":"CD005287","article-title":"Selective estrogen receptor modulators (SERMs) for uterine leiomyomas","volume":"10","author":"Deng","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_83","first-page":"CD009505","article-title":"Aromatase inhibitors for uterine fibroids","volume":"10","author":"Song","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s40265-024-02018-3","article-title":"Relugolix\/Estradiol\/Norethisterone Acetate: A Review in Endometriosis-Associated Pain","volume":"84","author":"Blair","year":"2024","journal-title":"Drugs"},{"key":"ref_85","unstructured":"European Medicines Agency (2022, September 21). Ryeqo 40 mg\/1 mg\/0.5 mg Film-Coated Tablets: EU Summary of Product Characteristics. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/ryeqo-epar-product-information_en.pdf."},{"key":"ref_86","first-page":"126","article-title":"Hysteroscopic myomectomy","volume":"16","author":"Piecak","year":"2017","journal-title":"Prz. Menopauzalny"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-0040-1713915","article-title":"Factors associated with complications of hysteroscopic myomectomy","volume":"42","author":"Lima","year":"2020","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00464-004-2181-8","article-title":"Complications in laparoscopic myomectomy","volume":"20","author":"Altgassen","year":"2006","journal-title":"Surg. Endosc."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0028-1102999","article-title":"Magnetic resonance-guided focused ultrasound for uterine fibroids","volume":"25","author":"Roberts","year":"2008","journal-title":"Semin. Interv. Radiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1111\/jog.15758","article-title":"Impact of diagnosis and treatment of uterine fibroids on quality of life and labor productivity: The Japanese online survey for uterine fibroids and quality of life (JOYFUL survey)","volume":"49","author":"Koga","year":"2023","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejogrb.2018.07.032","article-title":"Impact of uterine fibroids on quality of life: A national cross-sectional survey","volume":"229","author":"Katty","year":"2018","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(25)00728-7","article-title":"Current treatment for symptomatic uterine fibroids: Available evidence and therapeutic dilemmas","volume":"406","author":"Boomsma","year":"2025","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"275.e1","DOI":"10.1016\/j.ajog.2023.05.020","article-title":"Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids","volume":"229","author":"Anchan","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/AOG.0000000000002331","article-title":"Comparative effectiveness of uterine leiomyoma procedures using a large insurance claims database","volume":"130","author":"Borah","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s43441-023-00525-1","article-title":"Patient preferences regarding surgical treatment methods for symptomatic uterine fibroids","volume":"57","author":"Babalola","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"23743735211049655","DOI":"10.1177\/23743735211049655","article-title":"Patient recommendations for shared decision-making in uterine fibroid treatment decisions","volume":"8","author":"Riggan","year":"2021","journal-title":"J. Patient Exp."},{"key":"ref_97","first-page":"775","article-title":"Medical versus Surgical Management of Symptomatic Uterine Fibroids: A Systematic Review of Clinical Outcomes, Fertility, Safety, and Reintervention","volume":"7","author":"None","year":"2026","journal-title":"Int. J. Med. Pharm. Res."},{"key":"ref_98","unstructured":"National Institute for Health and Care Excellence (NICE) (2021). Heavy Menstrual Bleeding: Assessment and Management (NG88), NICE. Available online: https:\/\/www.nice.org.uk\/guidance\/ng88."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ijgo.12666","article-title":"The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions","volume":"143","author":"Munro","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_100","unstructured":"European Society for Gynaecological Endoscopy (ESGE) (2020). ESGE Good Practice Recommendations for Minimally Invasive Gynecologic Surgery. Facts Views Vis. Obgyn., 12, 5\u201349."},{"key":"ref_101","unstructured":"NICE Guideline Committee (2021). Uterine fibroids: Diagnosis and management within heavy menstrual bleeding guidelines. Heavy Menstrual Bleeding: Assessment and Management, NICE. NICE Guideline NG88."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2006). Myomas and reproductive function. Fertil. Steril., 86, S194\u2013S199.","DOI":"10.1016\/j.fertnstert.2006.08.026"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.52054\/FVVO.16.3.041","article-title":"European Society for Gynaecological Endoscopy (ESGE) Good Practice Recommendations on surgical techniques for removal of fibroids: Part 1 abdominal (laparoscopic and open) myomectomy","volume":"16","author":"Saridogan","year":"2024","journal-title":"Facts Views Vis. ObGyn"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"383","DOI":"10.52054\/FVVO.16.4.054","article-title":"European Society for Gynaecological Endoscopy (ESGE) Good Practice Recommendations on surgical techniques for Removal of Fibroids: Part 2 Hysteroscopic Myomectomy","volume":"16","author":"Clark","year":"2024","journal-title":"Facts Views Vis. ObGyn"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4632\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:45:18Z","timestamp":1781516718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":104,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124632"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124632","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}